Modeling & Simulation
Chair: Hartmut Derendorf
Co-Chair: Ping Zhao
The emphasis of this group is to focus on the role of modeling and simulation in drug development in all stages. Examples include translational extrapolations from preclinical data to clinical expectations, drug-drug interactions, extrapolations of PK/PD
data to special populations, early dose optimization and selection of doses for clinical testing, physiologically based pharmacokinetics, population pharmacokinetics and many others. Beyond just being a discussion forum this group will also aim to
generate and publish position papers on the role of modeling and simulation for good decision making in drug development and regulatory decisions.
The focus group will also maintain an active role at ISSX meetings, where members can meet and connect regularly to discuss progress and to recruit new members. The group will also aim to have targeted sessions at ISSX meetings that highlight new and
exciting science within our focus area. Furthermore, the focus group will reach out to other societies (ASCPT, ACCP, AAPS, ISOP, FIP) to join forces and interact closely on modeling and simulation topics.
Join this Focus Group